QMMM:NASDAQQMMM Holdings Limited Analysis
Data as of 2026-04-27 - not real-time
$119.40
Latest Price
9/10Risk
Risk Level: High
Executive Summary
QMMM is trading flat at its 20‑day and 50‑day SMA of $119.40, with an RSI of 62.5 indicating overbought conditions and a bearish MACD signal (negative histogram) suggesting limited upside. The stock shows a neutral trend direction and **zero 30‑day volatility**, yet its beta of 1.16 points to higher sensitivity to market moves. Volume is stable but effectively nil, reinforcing the lack of market participation.
Fundamentally, the company is severely overvalued – a price‑to‑book of 526 and price‑to‑sales of 3,640, combined with negative gross (0.8%), operating (‑115%) and profit margins (‑150%). Cash flow is deeply negative (operating cash flow ≈ ‑$6.35 B) and the balance sheet shows a high debt‑to‑equity of 1.6. The max drawdown of ‑65% and a recent securities class‑action investigation raise substantial red flags, making the stock a high‑risk proposition across all horizons.
Fundamentally, the company is severely overvalued – a price‑to‑book of 526 and price‑to‑sales of 3,640, combined with negative gross (0.8%), operating (‑115%) and profit margins (‑150%). Cash flow is deeply negative (operating cash flow ≈ ‑$6.35 B) and the balance sheet shows a high debt‑to‑equity of 1.6. The max drawdown of ‑65% and a recent securities class‑action investigation raise substantial red flags, making the stock a high‑risk proposition across all horizons.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 9/10
Key Factors
- Bearish MACD and overbought RSI
- Extreme overvaluation (PB 526, PS 3640)
- Ongoing securities class‑action investigation
Medium Term
1–3 yearsCautious
Model confidence: 8/10
Key Factors
- Sustained negative margins and cash flow
- High beta amplifying market risk
- Lack of trading liquidity
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Structural financial weakness
- Potential legal liabilities
- No dividend or earnings recovery signals
Key Metrics & Analysis
Financial Health
Revenue Growth-40.10%
Profit Margin-150.09%
ROE-198.06%
ROA-62.02%
Debt/Equity1.61
P/B Ratio526.0
Op. Cash Flow$-6351768
Free Cash Flow$-6274201
Industry P/E18.7
Technical Analysis
TrendNeutral
RSI62.5
Support$119.40
Resistance$119.40
MA 20$119.40
MA 50$119.40
MA 200$93.85
MACDBearish
VolumeStable
Fear & Greed Index88.02
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta1.16
0Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.